Loading stock data…
VEEV
$159.33-7.01 (-4.21%)
Market ClosedLast close May 11
Veeva Systems Inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Veeva Systems Inc. in the Healthcare sector is trading at $159.33. The stock is currently near its 52-week low of $148.05, remaining 31.9% below its 200-day moving average. Technical signals show neutral RSI of 42 and bullish MACD crossover, explaining why VEEV maintains its current current market pressure. The Whystock Score of 15/100 signals elevated caution as indicators diverge.
Ecosystem Influences
Neutral momentum (RSI 42) — price action in range
Long-term trend bearish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$159.33
Potential Downside
31.8%
Whystock Fair Value$108.59
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Analyst Consensus28 analysts
Buy
Mean target$264.46+66.0%
Range$176.00 – $350.00
Fundamentals
Veeva Systems Inc. provides cloud-based software for the life sciences industry in North America, Europe, the Asia Pacific, the Middle East, Africa, and Latin America. The company offers Veeva Commercial Cloud comprising Veeva Vault CRM Suite for pha...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$26.92B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
30.11
Beta
High-beta play. Expect amplified moves vs. the broad market.
1.10
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
12.60%
Volume
Today's trading volume
2.34M
Recent News
Hims & Hers Health, Inc. (HIMS) Reports Q1 Loss, Misses Revenue Estimates
Hims & Hers Health (HIMS) delivered earnings and revenue surprises of -519.58% and -1.86%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Why Veeva Systems (VEEV) Is Strengthening Its Life Sciences Data Moat
Veeva Systems Inc. (NYSE:VEEV) is one of the best stocks to buy with wide moats. The latest moat-relevant update came on May 6, 2026, when Snowflake said it was collaborating with Veeva Systems Inc. (NYSE:VEEV) to connect the Snowflake AI Data Cloud for Healthcare & Life Sciences with the Veeva Vault Platform. The new Snowflake […]
Can Platform Expansion Support Hims & Hers Stock Before Q1 Earnings?
HIMS first-quarter 2026 results are likely to benefit from Labs and branded weight loss medications even as higher costs and GLP-1 scrutiny linger.
Is It Time To Reconsider Veeva Systems (VEEV) After Recent Share Price Weakness
Investors may be wondering whether Veeva Systems at about US$168.25 is starting to look interesting, or if the stock still carries too much optimism in its price. Over the last week the share price has moved by 7.9%, compared with a 2.5% decline over 30 days and deeper returns of 23.3% year to date and 29.8% over the past year. Recent coverage has focused on Veeva Systems as a key healthcare software provider, with attention on how its role in life sciences workflows might affect sentiment...
Investors Heavily Search Veeva Systems Inc. (VEEV): Here is What You Need to Know
Zacks.com users have recently been watching Veeva (VEEV) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.